| P50 | author | Stanisław Jerzy Czuczwar | Q9342142 |
| | Marzena Ułamek-Kozioł | Q125315768 |
| | Anna Bogucka-Kocka | Q61139912 |
| | Ryszard Pluta | Q61471579 |
| | Janusz Kocki | Q90229866 |
| | Ryszard Maciejewski | Q97373129 |
| | Wanda Furmaga-Jabłońska | Q115982643 |
| | Judyta Jabłońska-Brzozowska | Q116198683 |
| | Sławomir Januszewski | Q125315679 |
| P2093 | author name string | Mirosław Jabłoński | |
| P2860 | cites work | Induction of presenilins in the rat brain after middle cerebral arterial occlusion | Q48184379 |
| | Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia | Q48213340 |
| | Progressive parenchymal deposition of beta-amyloid precursor protein in rat brain following global cerebral ischemia | Q48234682 |
| | Neuronal apolipoprotein E is not synthesized in neuron after focal ischemia in rat brain | Q48250395 |
| | Considerations of the ischemic basis and therapy of Alzheimer Disease | Q48263833 |
| | Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques | Q48283039 |
| | Alzheimer's Disease | Q22248111 |
| | Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein | Q22251280 |
| | Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease | Q24670696 |
| | Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease | Q24672501 |
| | Alpha-synuclein and neurodegenerative diseases | Q28204386 |
| | Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid | Q28279517 |
| | Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch | Q28346677 |
| | Presenilin-1 and intracellular calcium stores regulate neuronal glutamate uptake | Q28511563 |
| | Delayed, but prolonged increases in astrocytic clusterin (ApoJ) mRNA expression following acute cortical spreading depression in the rat: evidence for a role of clusterin in ischemic tolerance | Q28564850 |
| | Spatiotemporal changes of apolipoprotein E immunoreactivity and apolipoprotein E mRNA expression after transient middle cerebral artery occlusion in rat brain | Q28575942 |
| | Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis | Q28592853 |
| | Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans | Q28741472 |
| | Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 |
| | Alzheimer's disease is a synaptic failure | Q29547670 |
| | Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity | Q29616491 |
| | Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings | Q30599199 |
| | Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation | Q30803369 |
| | Role of blood vessels in producing pathological changes in the brain with Alzheimer's disease | Q30872231 |
| | Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease. | Q31108305 |
| | Hyperglycemic but not normoglycemic global ischemia induces marked early intraneuronal expression of beta-amyloid precursor protein. | Q31808112 |
| | Why Alzheimer's disease starts with a memory impairment: neurophysiological insight | Q33348900 |
| | Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity | Q33594690 |
| | Global ischemia and behavioural deficits | Q33643194 |
| | Alpha-synuclein in Lewy body disease and Alzheimer's disease | Q33750063 |
| | Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease | Q33782706 |
| | Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model | Q33943399 |
| | Are cerebrovascular factors involved in Alzheimer's disease? | Q33950384 |
| | The role of cerebral ischemia in Alzheimer's disease | Q33950413 |
| | Recovery of integrative central nervous function after one hour global cerebro-circulatory arrest in normothermic cat. | Q34191707 |
| | Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids | Q34255552 |
| | Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies | Q34991103 |
| | Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma | Q35103035 |
| | Astrocyte apoptosis: implications for neuroprotection | Q35737824 |
| | Microvessels from Alzheimer's disease brains kill neurons in vitro | Q35745283 |
| | High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice | Q35782286 |
| | Looking for the link between plaques and tangles | Q35785705 |
| | Alzheimer lesions after ischemia-reperfusion brain injury | Q35944273 |
| | From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease | Q36266186 |
| | Plaques and tangles and the pathogenesis of Alzheimer's disease. | Q36432461 |
| | Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease | Q36511844 |
| | Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death | Q36579857 |
| | Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease? | Q36582789 |
| | The enigma of vascular cognitive disorder and vascular dementia | Q36730292 |
| | Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain | Q36790976 |
| | Long-term functional consequences of transient occlusion of the middle cerebral artery in rats: a 1-year follow-up of the development of epileptogenesis and memory impairment in relation to sensorimotor deficits. | Q48312947 |
| | Estrogen attenuates over-expression of beta-amyloid precursor protein messager RNA in an animal model of focal ischemia | Q48351914 |
| | Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats | Q48365738 |
| | Cerebral accumulation of beta-amyloid following ischemic brain injury with long-term survival | Q48372538 |
| | Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat. | Q48376069 |
| | Extracellular amyloid formation and associated pathology in neural grafts | Q48382178 |
| | Reference and working memory of rats following hippocampal damage induced by transient forebrain ischemia | Q48398288 |
| | Vascular pathology in Alzheimer's disease | Q48426638 |
| | Astroglial expression of the beta-amyloid in ischemia-reperfusion brain injury | Q48426714 |
| | Dementia associated with lacunar infarction | Q48434074 |
| | Glial expression of the beta-amyloid peptide in cardiac arrest | Q48453629 |
| | White matter alterations following thromboembolic stroke: a beta-amyloid precursor protein immunocytochemical study in rats | Q48463401 |
| | Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus | Q48466817 |
| | Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia | Q48472027 |
| | Incidence of dementia after ischemic stroke: results of a longitudinal study | Q48491561 |
| | Global ischemic neuronal damage relates to behavioural deficits: a pharmacological approach | Q48522926 |
| | Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia | Q48607479 |
| | Changes in amyloid precursor protein and apolipoprotein E immunoreactivity following ischemic brain injury in rat with long-term survival: influence of idebenone treatment. | Q48634573 |
| | Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion | Q48682199 |
| | Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals | Q48687953 |
| | The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils | Q48690563 |
| | No effect of anti-oxidative therapy on cerebral amyloidosis following ischemia-reperfusion brain injury. | Q48721399 |
| | Immunodistribution of amyloid beta protein (Aβ) and advanced glycation end-product receptors (RAGE) in choroid plexus and ependyma of resuscitated patients | Q48732860 |
| | Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex | Q48737468 |
| | Poststroke dementia: incidence and relationship to prestroke cognitive decline | Q48760465 |
| | Possible reverse transport of beta-amyloid peptide across the blood-brain barrier. | Q48808547 |
| | Pathological opening of the blood-brain barrier to horseradish peroxidase and amyloid precursor protein following ischemia-reperfusion brain injury | Q48813389 |
| | Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease | Q48820847 |
| | Persistent behavioral impairments and neuroinflammation following global ischemia in the rat. | Q48821786 |
| | Accumulation of apolipoprotein E and beta-amyloid-like protein in a trace of the hippocampal CA1 pyramidal cell layer after ischaemic delayed neuronal death. | Q48858079 |
| | Expression of beta-amyloid precursor protein mRNAs following transient focal ischaemia | Q48863880 |
| | Cytotoxic fragment of amyloid precursor protein accumulates in hippocampus after global forebrain ischemia | Q48882742 |
| | Panax Notoginseng Burk attenuates impairment of learning and memory functions and increases ED1, BDNF and beta-secretase immunoreactive cells in chronic stage ischemia-reperfusion injured rats | Q48961615 |
| | Circulating beta amyloid protein is elevated in patients with acute ischemic stroke | Q49093865 |
| | Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus | Q49114133 |
| | Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia | Q48103035 |
| | Cerebral ischemia induces alterations in tau and ubiquitin proteins. | Q48128493 |
| | Changes in locomotor activity and passive avoidance task performance induced by cerebral ischemia in Mongolian gerbils | Q48163215 |
| | Transient brain ischemia due to cardiac arrest causes irreversible long-lasting cognitive injury. | Q48166593 |
| | Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain | Q36822847 |
| | Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease | Q37062573 |
| | The cost of cerebral ischaemia. | Q37198081 |
| | Stroke and dementia | Q37590452 |
| | Alzheimer's mechanisms in ischemic brain degeneration | Q37640009 |
| | Consideration of the ischaemic basis and treatment of Alzheimer's disease | Q37728997 |
| | Cognitive impairment with vascular impairment and degeneration | Q37948975 |
| | Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide. | Q38024763 |
| | Alzheimer's factors in postischemic dementia. | Q38044631 |
| | Ischemia signalling to Alzheimer-related genes. | Q38074101 |
| | Long-term cognitive and neuropsychological symptoms after global cerebral ischemia in Mongolian gerbils. | Q40328606 |
| | Micro-blood-brain barrier openings and cytotoxic fragments of amyloid precursor protein accumulation in white matter after ischemic brain injury in long-lived rats | Q40328614 |
| | Postischemic hyperthermia induces Alzheimer-like pathology in the rat brain | Q40585250 |
| | Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease | Q40621541 |
| | Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress | Q41830251 |
| | Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 |
| | Blood-brain barrier dysfunction and amyloid precursor protein accumulation in microvascular compartment following ischemia-reperfusion brain injury with 1-year survival | Q42456418 |
| | Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain | Q42476577 |
| | Platelet occlusion phenomenon after short- and long-term survival following complete cerebral ischemia in rats produced by cardiac arrest | Q42490102 |
| | Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest | Q42499063 |
| | Neurofibrillary tangle formation in the nucleus basalis of meynert ipsilateral to a massive cerebral infarct | Q42519461 |
| | Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. | Q42523862 |
| | Alterations in mRNA expression of BACE1, cathepsin B, and glutaminyl cyclase in mice ischemic brain | Q43266049 |
| | Alpha-synuclein protein is not scavenged in neuronal loss induced by kainic acid or focal ischemia | Q43568141 |
| | One year follow up in ischemic brain injury and the role of Alzheimer factors. | Q43722042 |
| | Factors in creepy delayed neuronal death in hippocampus following brain ischemia-reperfusion injury with long-term survival | Q43808470 |
| | Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis | Q43893370 |
| | Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells | Q43931362 |
| | Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort | Q44491519 |
| | Presenilin-1 interacts directly with the beta-site amyloid protein precursor cleaving enzyme (BACE1). | Q44538958 |
| | Temporal Dynamics of Degenerative and Regenerative Events Associated with Cerebral Ischemia in Aged Rats | Q44659812 |
| | Magnetic resonance imaging shows delayed ischemic striatal neurodegeneration | Q44697615 |
| | Microglial tau undergoes phosphorylation-independent modification after ischemia | Q44733703 |
| | Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats | Q44776053 |
| | Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease beta-secretase (BACE-1). | Q44825050 |
| | Increased beta-secretase activity and expression in rats following transient cerebral ischemia | Q44878523 |
| | Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein | Q45048594 |
| | Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) | Q45071059 |
| | Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes | Q45245016 |
| | Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. | Q46522758 |
| | Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats | Q46525415 |
| | Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease. | Q46649371 |
| | Adult mouse astrocytes degrade amyloid-beta in vitro and in situ | Q46779933 |
| | Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. | Q47750610 |
| | Ischemic blood-brain barrier and amyloid in white matter as etiological factors in leukoaraiosis | Q47957486 |
| | Impaired conditioned emotional response and object recognition are concomitant to neuronal damage in the amygdala and perirhinal cortex in middle-aged ischemic rats. | Q50648484 |
| | The costs of vascular dementia: a comparison with Alzheimer's disease. | Q50710138 |
| | Do silent brain infarctions predict the development of dementia after first ischemic stroke? | Q51034123 |
| | Functional outcome in patients with lacunar infarction. | Q51034130 |
| | Locomotor hyperactivity and hippocampal CA1 injury after transient forebrain ischemia of gerbils. | Q51717829 |
| | Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences | Q51903055 |
| | Dementia and cognitive impairment three months after stroke. | Q51960806 |
| | [mRNA expression and activity of ADAM17 in hippocampus after chronic cerebral hypoperfusion: experiment with aged rats]. | Q51968905 |
| | Clinical determinants of poststroke dementia. | Q51996933 |
| | Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. | Q52101186 |
| | Beta-protein immunoreactivity in the human brain after cardiac arrest. | Q52203708 |
| | Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. | Q52205308 |
| | A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats. | Q52935689 |
| | Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain | Q53201329 |
| | The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. | Q53207598 |
| | Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia. | Q53212645 |
| | Experimental model of neuropathological changes characteristic for Alzheimer's disease. | Q53220372 |
| | Post-ischemic changes in the expression of Alzheimer's APP isoforms in rat cerebral cortex. | Q53221749 |
| | Ischemic rats as a model in the study of the neurobiological role of human beta-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain. | Q53232300 |
| | Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion. | Q53243101 |
| | Delayed poststroke dementia: a 4-year follow-up study. | Q53262598 |
| | Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. | Q53265121 |
| | Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease. | Q53324010 |
| | Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? | Q53371212 |
| | Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus. | Q53390971 |
| | Unresolved questions concerning etiology of Alzheimer’s disease: Hypometabolism | Q53416559 |
| | The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-beta Levels: Resolubilization of amyloid-beta with transition metal ion chelators | Q59545714 |
| | Increased β-Amyloid Precursor Protein Expression in Astrocytes in the Gerbil Hippocampus Following Ischaemia: Association with Proliferation of Astrocytes | Q61039303 |
| | Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse | Q63966769 |
| | Induction of clusterin in the immature brain following a hypoxic-ischemic injury | Q71525724 |
| | Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide | Q71558906 |
| | Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils | Q71736000 |
| | Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study | Q71798371 |
| | Ultrastructural localization of amyloid protein precursor in the normal and postischemic gerbil brain | Q72235445 |
| | Glial expression of the beta-amyloid precursor protein (APP) in global ischemia | Q72333929 |
| | Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain | Q72346999 |
| | Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model | Q73337645 |
| | The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease | Q73808460 |
| | Transport of human beta-amyloid peptide through the rat blood-brain barrier after global cerebral ischemia | Q73991840 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 2.0 Generic | Q44128984 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | regulation of gene expression | Q411391 |
| | brain ischemia | Q4862390 |
| | Alzheimer's disease | Q11081 |
| P304 | page(s) | 500-515 | |
| P577 | publication date | 2013-03-22 | |
| P1433 | published in | Molecular Neurobiology | Q15716645 |
| P1476 | title | Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes | |
| P478 | volume | 48 | |